Abstract:Adverse side effects of drug drug interactions induced by human cytochrome P450 (CYP) inhibition is an important consideration, especially, during the research phase of drug discovery. It is highly desirable to develop computational models that can predict the inhibitive effect of a compound against a specific CYP isoform. In this study, inhibitor predicting models were developed for five major CYP isoforms, namely 1A2, 2C9, 2C19, 2D6, and 3A4, using a combined classifier algorithm on a large data set containing more than 24,700 unique compounds, extracted from PubChem. The combined classifiers algorithm is an ensemble of different independent machine learning classifiers including support vector machine, C4.5 decision tree, k-nearest neighbor, and naive Bayes, fused by a back-propagation artificial neural network (BP-ANN). All developed models were validated by 5-fold cross-validation and a diverse validation set composed of about 9000 diverse unique compounds. The range of the area under the receiver operating characteristic curve (AUC) for the validation sets was 0.764 to 0.815 for CYP1A2, 0.837 to 0.861 for CYP2C9, 0.793 to 0.842 for CYP2C19, 0.839 to 0.886 for CYP2D6, and 0.754 to 0.790 for CYP3A4, respectively, using the new developed combined classifiers. The overall performance of the combined classifiers fused by BP-ANN was superior to that of three classic fusion techniques (Mean, Maximum, and Multiply). The chemical spaces of data sets were explored by multidimensional scaling plots, and the use of applicability domain improved the prediction accuracies of models. In addition, some representative substructure fragments differentiating CYP inhibitors and noninhibitors were characterized by the substructure fragment analysis. These classification models are applicable for virtual screening of the five major CYP isoforms inhibitors or can be used as simple filters of potential chemicals in drug discovery.

Computational Prediction of the Isoform Specificity of Cytochrome P450 Substrates by an Improved Bayesian Method

Survey of Machine Learning Techniques for Prediction of the Isoform Specificity of Cytochrome P450 Substrates.

Investigation of in silico studies for cytochrome P450 isoforms specificity

Classification models for predicting cytochrome p450 enzyme-substrate selectivity

In Silico Prediction of Cytochrome P450-Mediated Biotransformations of Xenobiotics: A Case Study of Epoxidation.

Machine Learning Models to Predict Cytochrome P450 2B6 Inhibitors and Substrates

Improved Prediction of Michaelis Constants in CYP450-Mediated Reactions by Resilient Back Propagation Algorithm.

Prediction of the Functional Consequences of Single Amino Acid Substitution in Human Cytochrome P450

Classification of Cytochrome P450 Inhibitors and Noninhibitors Using Combined Classifiers.

Prediction of Cytochrome P450 Inhibition Using a Deep Learning Approach and Substructure Pattern Recognition

In Silico Prediction of CYP2C8 Inhibition with Machine-Learning Methods

Prediction of cytochrome P4502C9 inhibitors based on molecular indices

DeepP450: Predicting Human P450 Activities of Small Molecules by Integrating Pretrained Protein Language Model and Molecular Representation

Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes

Improved Prediction Of Drug-Target Interactions Based On Ensemble Learning With Fuzzy Local Ternary Pattern

Harnessing machine learning to predict cytochrome P450 inhibition through molecular properties

Classification Of Cytochrome P450 1a2 Inhibitors And Noninhibitors Based On Deep Belief Network

Prediction of CYP450 Enzyme-Substrate Selectivity Based on the Network-Based Label Space Division Method

Computational methods and tools to predict cytochrome P450 metabolism for drug discovery

Prediction of Cytochrome P450 Substrates Using the Explainable Multitask Deep Learning Models

Prediction of human cytochrome P450 inhibition using a multi-task deep autoencoder neural network.